News

The most complete picture yet is coming into focus of how antibodies produced in people who effectively fight off SARS-CoV-2 work to neutralize the part of the virus responsible for causing infection. In the journal Science, researchers at The University of Texas at Austin describe the finding, which represents good news for designing the next generation of vaccines to protect against variants of the virus or future emerging coronaviruses.

For more than a decade, the Aspire Awards have provided an occasion for faculty, staff and students to recognize undergraduate leaders in the College of Natural Sciences. The event celebrates undergraduate students from underrepresented groups in the sciences, recognizing their achievements in research, service and leadership. This year, 25 students were given Aspire awards in several categories. The event is a collaboration between the college's Office of Undergraduate Education and the student-led Black and Latinx Advocacy Council.

The tree of life just got a little bigger: A team of scientists from the U.S. and China has identified an entirely new group of microbes quietly living in hot springs, geothermal systems and hydrothermal sediments around the world. The microbes appear to be playing an important role in the global carbon cycle by helping break down decaying plants without producing the greenhouse gas methane.

​In search of a way to reduce the amount of plastic pollution an individual creates, a team of undergraduates in the UT Austin Inventors Program are exploring how mealworms, and the microbes in their guts, can naturally degrade household plastics.

More effective antiviral treatments could be on the way after research from The University of Texas at Austin sheds new light on the COVID-19 antiviral drug remdesivir, the only treatment of its kind currently approved in the U.S. for the coronavirus.

An antibody test for the virus that causes COVID-19, developed by researchers at The University of Texas at Austin in collaboration with Houston Methodist and other institutions, is more accurate and can handle a much larger number of donor samples at lower overall cost than standard antibody tests currently in use. In the near term, the test can be used to accurately identify the best donors for convalescent plasma therapy and measure how well candidate vaccines and other therapies elicit an immune response.

They may be tiny, but leafhoppers have a super power: they secrete a substance that makes their bodies water-repellant and anti-reflective, which may help them blend in with their surroundings and escape surface tension. Symbiotic bacteria living in the leafhoppers appear to assist in producing the substance and its soccer-ball-shaped nanostructures called brochosomes, but the process is something of a mystery.

Responding to a need to quickly develop billions of doses of lifesaving COVID-19 vaccines, a scientific team at The University of Texas at Austin has successfully redesigned a key protein from the coronavirus, and the modification could enable much faster and more stable production of vaccines worldwide.

As terrifying as the current pandemic is, scientists believe some of the hundreds of other known coronaviruses in bats might also have the potential to make the cross-species leap into humans, as this one probably did. Scientists are already thinking about ways to prevent another coronavirus from spiraling out of control. Basic research published in the journal Science provides evidence that an antibody therapy that's effective against all SARS-like coronaviruses is possible.